These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9882290)

  • 41. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.
    Naif HM; Cunningham AL; Alali M; Li S; Nasr N; Buhler MM; Schols D; de Clercq E; Stewart G
    J Virol; 2002 Apr; 76(7):3114-24. PubMed ID: 11884536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS.
    Klein RS; Williams KC; Alvarez-Hernandez X; Westmoreland S; Force T; Lackner AA; Luster AD
    J Immunol; 1999 Aug; 163(3):1636-46. PubMed ID: 10415069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of nucleotide sequences in the V3 region in efficient replication of CCR5-utilizing human immunodeficiency virus type 1 in macrophages.
    Harada T; Tsunetsugu-Yokota Y; Koyanagi Y; Sata T; Kurata T; Kojima A
    Virology; 2002 Aug; 299(2):192-203. PubMed ID: 12202222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.
    Gabuzda D; Wang J
    J Neurovirol; 2000 May; 6 Suppl 1():S24-32. PubMed ID: 10871762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
    Sato H; Kato K; Takebe Y
    Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
    J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.
    Singh A; Collman RG
    J Virol; 2000 Nov; 74(21):10229-35. PubMed ID: 11024154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
    Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
    J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia.
    Zheng J; Ghorpade A; Niemann D; Cotter RL; Thylin MR; Epstein L; Swartz JM; Shepard RB; Liu X; Nukuna A; Gendelman HE
    J Virol; 1999 Oct; 73(10):8256-67. PubMed ID: 10482576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.
    Westby M; Smith-Burchnell C; Mori J; Lewis M; Mosley M; Stockdale M; Dorr P; Ciaramella G; Perros M
    J Virol; 2007 Mar; 81(5):2359-71. PubMed ID: 17182681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.
    Miller ED; Duus KM; Townsend M; Yi Y; Collman R; Reitz M; Su L
    J Virol; 2001 Sep; 75(18):8498-506. PubMed ID: 11507195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular tropisms and co-receptor usage of HIV-1 isolates from vertically infected children with neurological abnormalities and rapid disease progression.
    McCarthy M; He J; Auger D; Geffin R; Woodson C; Hutto C; Wood C; Scott G
    J Med Virol; 2002 May; 67(1):1-8. PubMed ID: 11920811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.